ICON applies IBM Watson Clinical Trial Matching to Oncology Clinical Trials Dublin, Ireland, 10 September, 2015 – ICON plc, (NASDAQ: ICLR) a global provider of drug development solutions and services ...
The companies will combine their extensive expertise and data sets to enhance Citeline Study Feasibility and help clinical trial teams accelerate the time to first and last patient in Informa Pharma ...
DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ:ICLR) a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced that ...
NEW YORK, Oct. 13, 2021 (GLOBE NEWSWIRE) -- Informa Pharma Intelligence, the global business intelligence provider for the biopharma industry, today announced its partnership with ICON plc, one of the ...